← Find more feeds

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated 9 minutes ago

Type-IB variations: questions and answers

about 1 hour ago

Type-IB variations: questions and answers

Read full

Type-II variations: questions and answers

about 1 hour ago

Type-II variations: questions and answers

Read full

Worksharing: questions and answers

13 minutes ago

Worksharing: questions and answers

Read full

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes

about 1 hour ago

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure...

Read full

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

about 1 hour ago

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

Read full

Azactam

3 days ago

Azactam

Read full

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 18, Status: Withdrawn

3 days ago

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of...

Read full

EMA workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia, Online, from 30 June 2026, 14:00 (CEST) to 30 June 2026, 18:00 (CEST)

6 days ago

EMA workshop on the challenges in drug development, regulation and clinical practice...

Read full

Human medicines European public assessment report (EPAR): Fendrix, hepatitis B (rDNA) vaccine (adjuvanted, adsorbed), Date of authorisation: 02/02/2005, Revision: 13, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Fendrix, hepatitis B (rDNA) vaccine...

Read full

CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025) and EMANS 2028 Strategic Overview (Theme 4)

3 days ago

CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025)...

Read full

Antimicrobial resistance in veterinary medicine

3 days ago

Antimicrobial resistance in veterinary medicine

Read full

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 28/02/2011, Revision: 38, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation...

Read full

Or log in

Everything you care about in one place

What's new

Latest posts

Type-IB variations: questions and answers

Type-II variations: questions and answers

Worksharing: questions and answers

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

Azactam

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 18, Status: Withdrawn

EMA workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia, Online, from 30 June 2026, 14:00 (CEST) to 30 June 2026, 18:00 (CEST)

Human medicines European public assessment report (EPAR): Fendrix, hepatitis B (rDNA) vaccine (adjuvanted, adsorbed), Date of authorisation: 02/02/2005, Revision: 13, Status: Authorised

CVMP activities related to antimicrobials - Status report on EMA/CVMP activities (2021–2025) and EMANS 2028 Strategic Overview (Theme 4)

Antimicrobial resistance in veterinary medicine

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 28/02/2011, Revision: 38, Status: Authorised

Try Feeder for free